Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
BICO Acquires Allegro 3D, Adding New Light-based 3D Bioprinting Technology – Complementing the Existing Offering of Application Tailored Products
BICO has acquired all the shares in San Diego-based Allegro 3D Inc. (“Allegro 3D”) for […]
CELLINK Launches the BIO CELLX, a First of its Kind Biodispensing Platform to Automate 3D Cell Culture
Today CELLINK, A BICO Company, launched the BIO CELLX a novel system that automates 3D […]
Biosero Expands Laboratory Automation Capabilities with New Product Launches
Biosero, Inc., a BICO company, and a developer of laboratory automation solutions to orchestrate scientific […]
BICO Partners with the Center for Contemporary Sciences (CCS) to Reduce Animal Testing in Life Sciences
Today BICO, a leading bio convergence company, announced a partnership with the Center for Contemporary […]
CELLINK and Nanoscribe Join Forces to Launch the Quantum X Bio, the World’s Most Accurate 3D Bioprinter
Today, BICO companies CELLINK and Nanoscribe announced the launch of the Quantum X bio, a revolutionary printing platform providing […]
BICO and Nanochon Announce Commercial Agreement to Develop 3D Printed Joint Restoration Implant
Today BICO, the world’s leading bio convergence company, announced partnership with Nanochon, a startup developing regenerative joint replacements. Under […]
BICO’s CYTENA Signs USD 10 Million Deal to Distribute Single Cell Isolators in China to Accelerate Development of Next Generation Therapies
Today CYTENA, a BICO company, announced it has signed a 2-year deal with Applitech Pharmaceutical Equipment Technology to […]
BICO Announces Appointment of Susan Tousi as New Member of the Board of Directors
Today BICO, the world’s leading Bio Convergence company announced it has added Susan Tousi to […]
CYTENA Launches C.STATION, a Fully Automated Platform for Stable Cell Line Development to Streamline Production of Antibody and Gene Therapies
Today CYTENA, a BICO company, launched C.STATION, a new platform for fully automated stable cell line development. The […]
BICO Strengthens IP Portfolio with Patents in the United States and Sweden for 3D Bioprinting of Temperature Sensitive Bioinks
BICO, the world’s leading bio convergence company, has been granted two patents relating to the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more